The appeal seeking an increased rating for exophthalmos was dismissed due to the untimeliness of the Notice of Disagreement (NOD). The Board remanded the issue of entitlement to an increased rating for hypothyroidism.
The deciding factor: The March 2025 NOD regarding the exophthalmos claim was untimely, and no good cause was shown. The hypothyroidism claim requires further development due to an inadequate VA examination.
- Claimed conditions
- exophthalmos, hypothyroidism
- How they argued it
- Direct service connection
- Exposure basis
- None
- Rating assigned
- None in this decision
- Decision date
- June 3, 2025
- Citation
- A25049109
What this means for you
A dismissal means the Board did not decide the issue on its merits — usually because it was withdrawn or had become moot. It says more about procedure than about whether a claim like this can win.
What you can do next
Related decisions
Other Board decisions on a similar condition or argued the same way.
- Denied
The Board denied service connection for a deviated septum and denied compensable ratings for allergic rhinitis, chronic sinusitis, hypothyroidism, and hypertension.
- Granted
The Board granted service connection for hypothyroidism, as it is presumptively linked to herbicide agent exposure during the Veteran's service in Vietnam.
- Denied
The Board denied an initial compensable disability rating for service-connected hypothyroidism and remanded the claim for service connection for lipomas (claimed as cysts surgery).
- Granted
The Board granted service connection for hypothyroidism secondary to in-service toxic exposure risk activity (TERA) based on the Veteran's conceded in-service jet fuel fumes exposure.
We are not the VA. Veterans’ Rights is an independent resource built for veterans. We are not the U.S. Department of Veterans Affairs, not part of the government, and not endorsed by any government agency.
This is general information, not legal advice. For advice about your own situation, talk to a VA-accredited representative — many help for free.